Director, HTA, Evidence, Global Access

🕒 April 30

Apply Now

Find Similar Remote Jobs

Set Up Email Alert For New Jobs

📊 Check your resume score for this job

Improve your chances of getting an interview by checking your resume score before you apply.

Upload Resume

Iovance Biotherapeutics, Inc.

WebsiteLinkedInAll Job Openings

501 - 1000 employees

Founded 2014

🧬 Biotechnology

💊 Pharmaceuticals

⚕️ Healthcare Insurance

Biotechnology • Pharmaceuticals • Healthcare Insurance

Iovance Biotherapeutics, Inc. is pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and attack diverse cancer cells in each patient. The company focuses on T-cell-based immunotherapy, specifically Tumor Infiltrating Lymphocyte (TIL) therapy, which involves reinvigorating a patient’s TILs to fight cancer. Iovance's TIL therapy is being investigated in clinical trials across multiple advanced solid tumor cancers. Additionally, the company is advancing genetically modified TIL therapies and exploring potential applications of PBL (peripheral blood lymphocyte) therapy for blood cancers. As a leader in cell therapy, Iovance owns a state-of-the-art Cell Therapy Center in Philadelphia for manufacturing their therapies using proprietary GMP. The company is at the forefront of developing personalized and patient-specific cancer treatments.

📋 Description

• Support the development and maintenance of economic models and global value dossiers for HTA submissions, managing/directing market access and HEOR consultants. • Serve as project manager for global market access and HEOR activities, including tracking deliverables, coordinating document reviews, managing contracts, and ensuring alignment on timelines and cross-functional updates. • Support global HEOR research projects, including review of analyses and development of publications for HTA submissions and payer responses, in collaboration with the HEOR team. • Support development and execution of the evidence generation for payer needs in collaboration with medical affairs • Manage external engagements, in a compliant manner, with HTA agencies, payers, key opinion leaders, and other stakeholders • Communicate market access and HEOR strategy updates, insights, and recommendations to cross-functional partners and senior leadership. • Develop and adapt value and access materials for priority global markets. • Support planning and strategy for new indication launches, from the perspective of evidence and access • Monitor and proactively communicate market access changes, challenges, and opportunities in priority markets. • Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics. • Perform miscellaneous duties as assigned.

🎯 Requirements

• 12+ years of relevant experience in the biopharmaceutical industry, with demonstrated expertise in health economics, outcomes research, market access, real world evidence and/or related functions. • Strong background in oncology, cell therapy, ATMPs, and/or rare diseases preferred. • Advanced degree preferred in a field related to HEOR (health economics, epidemiology, health services research or similar), or a medical field. • Experience and ability in developing strategic analyses and plans • Strong understanding of scientific, clinical, and real-world evidence, with the ability to communicate complex concepts clearly. • Excellent written and verbal communication skills, including significant experience presenting to executive-level audiences. • Highly organized with excellent project management skills • Deep understanding of international healthcare systems, including HTA processes, reimbursement frameworks, and health policy considerations across global markets. • Fluency in French or German would be an asset.